Mollii Suit and Fibromyalgia (EXOFIB 2)

S

Sheikh Shakhbout Medical City

Status

Enrolling

Conditions

Fibromyalgia
Muscular Diseases
Neuromuscular Diseases
Nervous System Diseases
Rheumatic Diseases

Treatments

Device: EXOPULSE Mollii Suit Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06226376
EXOFIB2

Details and patient eligibility

About

The goal of this clinical trial is to demonstrate the improvement of fibromyalgia syndrome obtained following active stimulation compared to sham, with diminished functional disability and improved health status using Exopulse Molli suit stimulation. The main questions it aims to answer are: Evaluation of pain, fatigue, mood and quality of life changes observed after active stimulation in comparison to sham. Improvement of fibromyalgia syndrome as per the Fibromyalgia Impact Questionnaire (FIQ) Study subjects will participate in: A randomized sham controlled double-blind trial to demonstrate the improvement of pain, quality of life, fatigue and mood in adult patients with fibromyalgia following a 2-week intervention of "active" versus "sham" Exopulse Mollii suit. A 2-week washout period should be enough to prevent a potential carry over effect. After this phase (phase 1), a second open label phase (phase 2) will be proposed for patients to understand the effects of Exopulse Mollii suit employed for 4 weeks (7 sessions per week) on the studied outcomes.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 18 and 75 years, with a definite diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) 2010 criteria, set for at least one month.
  • Patients should be able to understand verbal instructions.

Exclusion criteria

  • Patient with VAS < 4
  • Patient included in another research protocol during the study period
  • Patient unable to undergo medical monitor for the study purposes due to geographical or social reasons
  • Patient with contraindication to wearing Exopulse Mollii suit (e.g., cardiac stimulator, a ventriculoperitoneal shunt, intrathecal baclofen pump, pregnancy, and/or body mass index above 35 kg/m2)
  • Patient with other somatic or psychiatric diagnoses other than anxiety and depression (e.g., arrhythmias, uncontrolled epilepsy, other diseases causing osteoarticular and muscular pain)
  • Any change in the pharmacological therapy in the last three months
  • Introduction of a medical device other than Exopulse Mollii suit during the study period
  • Patient under juridical protection

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

34 participants in 2 patient groups

EXOPULSE Mollii Suit Stimulation Active.
Active Comparator group
Description:
This will be the EXOPULSE Mollii Suit Active Stimulation. Stimulation will go on for 60 minutes while control unit is on for 60 minutes.
Treatment:
Device: EXOPULSE Mollii Suit Stimulation
EXOPULSE Mollii Suit Stimulation Sham.
Sham Comparator group
Description:
This will be the EXOPULSE Mollii Suit Sham Stimulation. Stimulation will go on for 1 minute then it turns off while the control unit will remain on for total of 60 minutes
Treatment:
Device: EXOPULSE Mollii Suit Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Hasan M Jaber, Bsc; Naji J Riachi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems